Summary
74 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Earnings per share grew by 14% a year over the last 3 years.
What to watch
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 15.7 JPY for 1 JPY of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (JPY)
Diluted EPS (JPY)
- Analyst estimate
Revenue grew by 9.1% a year over 5 years. Over the last 3 years it grew by 11% a year. Earnings per share grew by 14% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 JPY of revenue goes
- Cost of sales 14 JPY
- Sales and administration 69 JPY
- Taxes and other 8.5 JPY
- Net profit 9.1 JPY
Net profit, industry median (Personal Products & Services) 7.5 JPY
Out of every 100 JPY of revenue, 9.1 JPY is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenIts debt is larger than its cash. The debt score is high even so.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail